Evaluation of a School-based Influenza Vaccination Program
NCT00961337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7854
Last updated 2009-08-18
Summary
The purpose of this study is to determine whether inactivated influenza vaccines are effective to protect school children and their households from getting influenza infection and further prevent student's absenteeism.
Conditions
- Influenza
- Influenza Vaccines
Interventions
- BIOLOGICAL
-
Trivalent inactivated influenza vaccine
one dose
Sponsors & Collaborators
-
Public Health Bureau,Taoyan County Governmnet, Taiwan
collaborator UNKNOWN -
Education Department,Taoyan County Governmnet, Taiwan
collaborator OTHER -
Centers for Disease Control, Taiwan
lead OTHER_GOV
Principal Investigators
-
Jen-Hsiang Chunag, MD, MS, PhD. · National Health Command Center, Centers for disease control, Department of Health, Taiwan, R.O.C
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
NCT01995851 ·Status: COMPLETED
-
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population
NCT01007201 ·Status: COMPLETED ·Phase: NA
-
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
NCT00934245 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine Effectiveness in Among Young Children in Taiwan
NCT06446232 ·Status: RECRUITING
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
NCT00138294 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Flu Vaccine in Children
NCT00001127 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects
NCT01752881 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
NCT03293732 ·Status: COMPLETED ·Phase: PHASE1
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 ·Status: COMPLETED
-
A Post Marking Study to Evaluate the Safety of FluMist in Children
NCT00569894 ·Status: COMPLETED
-
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
NCT01736709 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05313893 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
NCT00333398 ·Status: COMPLETED ·Phase: PHASE3
-
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
NCT00792051 ·Status: COMPLETED ·Phase: NA
-
Influenza Immunization of Children in India
NCT01680679 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old
NCT01356342 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders
NCT01003145 ·Status: COMPLETED ·Phase: NA
-
Comparison of Flu Vaccine Doses in Children
NCT01164553 ·Status: COMPLETED ·Phase: PHASE1